Leveraging Continuous Biomanufactuing Within a kojoX™ Ecosystem for Improved Accessibility to Complex Biotherapeutics

With an increasing industry emphasis on complex modalities, sustainable manufacturing and medicine accessibility, the spotlight has been cast on continuous biomanufacturing as a solution. Our MaruX™ technology platform provides a third dimension to our scale-up and scale-out offering that can be leveraged for the production of complex molecules, bi-specifics, tri-specifics, and fusion proteins in cost-effective ways from clinical through to commercial scale. Sustainable manufacturing is achieved by reducing energy costs and manufacturing facility footprint, through process intensification and automation that enhance clean-room efficiencies. While our SymphonX™ technology enables both continuous and fed-batch manufacturing within one facility, offering flexibility for production processes. Both systems form an integral part of our kojoX™ globally harmonised ecosystem - designed to enable high quality bioproduction, faster tech transfer, supply chain resilience and reduced regulatory burden - delivering unmatched speed to market of life-changing medicines for both stainless steel and single use biomanufacturing.